Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

Identifying Health Information Technology Needs of Oncologists to Facilitate the Adoption of Genomic Medicine: Recommendations From the 2016 American Society of Clinical Oncology Omics and Precision ...

An expert in Clinical Trials from the University of Nottingham is part of an international team of experts who have come together to enhance clinical ...

Community-based clinical trials hold much promise for modernizing the way we develop new treatments for the patients who need them. Their community-embedded design can improve diversity, increasing ...

Clinical trials are an essential part of medical breakthroughs that help patients, but getting them off the ground and running them is often fraught with challenges. Specifically, qualification, ...

What Are Clinical Trials for MASH? Clinical trials for MASH are research studies that evaluate potential new treatments for a form of liver disease called metabolic dysfunction-associated ...

Miriam Dervan, founder & CEO of mdgroup, discusses how patient-centered strategies rooted in empathy and advocacy engagement ...

Fred Hutch Cancer Center is committed to inclusivity in clinical trials. We recognize that it is essential to have a wide range of people from different communities participate in clinical trials to ...

What happens to a patient after I refer them to a clinical trial? Do they leave my practice? Referring patients to a clinical trial is similar to referring them to a specialist. They remain your ...